{"id":63614,"date":"2023-04-18T10:09:08","date_gmt":"2023-04-18T14:09:08","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/?p=63614"},"modified":"2023-06-06T18:24:57","modified_gmt":"2023-06-06T22:24:57","slug":"dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/","title":{"rendered":"Dr. Rumey Ishizawar\u2019s Research Finds Rheumatoid Arthritis Patients May Safely Receive Immune Checkpoint Inhibitors for Cancer Treatment"},"content":{"rendered":"

\"\"<\/a>The study evaluated whether pre-existing rheumatoid arthritis was associated with a higher mortality and risk for immune-related adverse events with immune checkpoint inhibitor use.<\/p>\n

Joining Dr. Ishizawar in conducting this research were UNC colleagues; Dr. Amanda Lusa, Dr. Todd Schwartz, Carolina Alvarez, and Shruti Saxena Beem.<\/p>\n

Learn more about the study findings via this summary in Rheumatology Advisor<\/a>.<\/p>\n

Rumey Ishizawar,<\/a> MD, PhD, is an assistant professor of medicine in the Division of Rheumatology, Allergy and Immunology.\u00a0<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

The study evaluated whether pre-existing rheumatoid arthritis was associated with a higher mortality and risk for immune-related adverse events with immune checkpoint inhibitor use. Joining Dr. Ishizawar in conducting this research were UNC colleagues; Dr. Amanda Lusa, Dr. Todd Schwartz, Carolina Alvarez, and Shruti Saxena Beem. Learn more about the study findings via this summary … Read more<\/a><\/p>\n","protected":false},"author":112673,"featured_media":37026,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[2,103],"tags":[632],"class_list":["post-63614","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-rheumatology","tag-632","odd"],"acf":[],"yoast_head":"\nDr. Rumey Ishizawar\u2019s Research Finds Rheumatoid Arthritis Patients May Safely Receive Immune Checkpoint Inhibitors for Cancer Treatment | Department of Medicine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr. Rumey Ishizawar\u2019s Research Finds Rheumatoid Arthritis Patients May Safely Receive Immune Checkpoint Inhibitors for Cancer Treatment | Department of Medicine\" \/>\n<meta property=\"og:description\" content=\"The study evaluated whether pre-existing rheumatoid arthritis was associated with a higher mortality and risk for immune-related adverse events with immune checkpoint inhibitor use. Joining Dr. Ishizawar in conducting this research were UNC colleagues; Dr. Amanda Lusa, Dr. Todd Schwartz, Carolina Alvarez, and Shruti Saxena Beem. Learn more about the study findings via this summary … Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Medicine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UNCDeptMedicine\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-18T14:09:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-06T22:24:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2124\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Morgan Duerden\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:site\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Morgan Duerden\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/\"},\"author\":{\"name\":\"Morgan Duerden\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/99bd6d3f6c7b07d9e318254957f14bf9\"},\"headline\":\"Dr. Rumey Ishizawar\u2019s Research Finds Rheumatoid Arthritis Patients May Safely Receive Immune Checkpoint Inhibitors for Cancer Treatment\",\"datePublished\":\"2023-04-18T14:09:08+00:00\",\"dateModified\":\"2023-06-06T22:24:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/\"},\"wordCount\":94,\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-scaled.jpg\",\"keywords\":[\"2023\"],\"articleSection\":[\"News\",\"Rheumatology, Allergy and Immunology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/\",\"name\":\"Dr. Rumey Ishizawar\u2019s Research Finds Rheumatoid Arthritis Patients May Safely Receive Immune Checkpoint Inhibitors for Cancer Treatment | Department of Medicine\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-scaled.jpg\",\"datePublished\":\"2023-04-18T14:09:08+00:00\",\"dateModified\":\"2023-06-06T22:24:57+00:00\",\"author\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/99bd6d3f6c7b07d9e318254957f14bf9\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-scaled.jpg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-scaled.jpg\",\"width\":2124,\"height\":2560,\"caption\":\"Rumey Ishizawar, MD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/medicine\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr. Rumey Ishizawar\u2019s Research Finds Rheumatoid Arthritis Patients May Safely Receive Immune Checkpoint Inhibitors for Cancer Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/\",\"name\":\"Department of Medicine\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/99bd6d3f6c7b07d9e318254957f14bf9\",\"name\":\"Morgan Duerden\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/57f0eedf80fc45b7a94c3d33d08ce4aa6767c429f14f57947b631c0f284f6cc2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/57f0eedf80fc45b7a94c3d33d08ce4aa6767c429f14f57947b631c0f284f6cc2?s=96&d=mm&r=g\",\"caption\":\"Morgan Duerden\"},\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/author\/duerdenm\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr. Rumey Ishizawar\u2019s Research Finds Rheumatoid Arthritis Patients May Safely Receive Immune Checkpoint Inhibitors for Cancer Treatment | Department of Medicine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/","og_locale":"en_US","og_type":"article","og_title":"Dr. Rumey Ishizawar\u2019s Research Finds Rheumatoid Arthritis Patients May Safely Receive Immune Checkpoint Inhibitors for Cancer Treatment | Department of Medicine","og_description":"The study evaluated whether pre-existing rheumatoid arthritis was associated with a higher mortality and risk for immune-related adverse events with immune checkpoint inhibitor use. Joining Dr. Ishizawar in conducting this research were UNC colleagues; Dr. Amanda Lusa, Dr. Todd Schwartz, Carolina Alvarez, and Shruti Saxena Beem. Learn more about the study findings via this summary … Read more","og_url":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/","og_site_name":"Department of Medicine","article_publisher":"https:\/\/www.facebook.com\/UNCDeptMedicine","article_published_time":"2023-04-18T14:09:08+00:00","article_modified_time":"2023-06-06T22:24:57+00:00","og_image":[{"width":2124,"height":2560,"url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-scaled.jpg","type":"image\/jpeg"}],"author":"Morgan Duerden","twitter_card":"summary_large_image","twitter_creator":"@uncdeptmedicine","twitter_site":"@uncdeptmedicine","twitter_misc":{"Written by":"Morgan Duerden","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/"},"author":{"name":"Morgan Duerden","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/99bd6d3f6c7b07d9e318254957f14bf9"},"headline":"Dr. Rumey Ishizawar\u2019s Research Finds Rheumatoid Arthritis Patients May Safely Receive Immune Checkpoint Inhibitors for Cancer Treatment","datePublished":"2023-04-18T14:09:08+00:00","dateModified":"2023-06-06T22:24:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/"},"wordCount":94,"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-scaled.jpg","keywords":["2023"],"articleSection":["News","Rheumatology, Allergy and Immunology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/","url":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/","name":"Dr. Rumey Ishizawar\u2019s Research Finds Rheumatoid Arthritis Patients May Safely Receive Immune Checkpoint Inhibitors for Cancer Treatment | Department of Medicine","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-scaled.jpg","datePublished":"2023-04-18T14:09:08+00:00","dateModified":"2023-06-06T22:24:57+00:00","author":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/99bd6d3f6c7b07d9e318254957f14bf9"},"breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#primaryimage","url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-scaled.jpg","contentUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-scaled.jpg","width":2124,"height":2560,"caption":"Rumey Ishizawar, MD"},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/medicine\/"},{"@type":"ListItem","position":2,"name":"Dr. Rumey Ishizawar\u2019s Research Finds Rheumatoid Arthritis Patients May Safely Receive Immune Checkpoint Inhibitors for Cancer Treatment"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/medicine\/#website","url":"https:\/\/www.med.unc.edu\/medicine\/","name":"Department of Medicine","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/99bd6d3f6c7b07d9e318254957f14bf9","name":"Morgan Duerden","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/57f0eedf80fc45b7a94c3d33d08ce4aa6767c429f14f57947b631c0f284f6cc2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/57f0eedf80fc45b7a94c3d33d08ce4aa6767c429f14f57947b631c0f284f6cc2?s=96&d=mm&r=g","caption":"Morgan Duerden"},"url":"https:\/\/www.med.unc.edu\/medicine\/news\/author\/duerdenm\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-scaled.jpg","featured_image_medium":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-249x300.jpg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-768x926.jpg","featured_image_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-850x1024.jpg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/09\/Rumey-Ishizawar-mv-150x150.jpg","featured_image_alt":"Rumey Ishizawar, MD","category_details":[{"name":"News","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/news\/"},{"name":"Rheumatology, Allergy and Immunology","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/rheumatology\/"}],"tag_details":[{"name":"2023","link":"https:\/\/www.med.unc.edu\/medicine\/news\/tag\/2023\/"}],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/63614","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/users\/112673"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/comments?post=63614"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/63614\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media\/37026"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media?parent=63614"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/categories?post=63614"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/tags?post=63614"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}